Brain AVM Study
A Randomized Multicenter Clinical Trial of Unruptured Brain Arteriovenous Malformation (ARUBA)
Protocol ID
06.02.063
Protocol Description
The purpose of this study is to determine whether it is better to treat an unruptured arteriovenous malformation (brain AVM) with one or more of several interventional procedures (e.g., surgery) intended to eliminate the brain AVM or rely on medical therapy to control symptoms.
Eligibility Criteria
Patients with unruptured arteriovenous malformations (brain AVMs)
Primary Investigator(s)
- Richard Libman, MD
Contact Information
Last Update
April 12, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Breast Cancer - Clinical Trial, Combination Therapy (06-083)
- Osteonecrosis of the Jaw - Case Control Study (07.08.127)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- ADHD Medication Adherence: Parent-Provider Study (06.08.072T)
- Bipolar Disorder - Clinical Trial (08-001)
- Bipolar Susceptibility Study (08-132)
- Cancer - Whole Brain Radiotherapy Study (08-225)
- Schizophrenia - Clinical Trial (05.04.086)
- Smoking Cessation - Lozenge vs. Patch (06-030)
- Respiratory Papillomatosis - Celebrex Study (03.02.131)
- Brain Tumor - Tissue Donation Study (06-086)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- CF - Expanded Access Study (07-02-201)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- HIV - Clinical Trial (08-02-160)
- Asthma - Clinical Trial (08-02-188)
- Metastatic Brain Tumor Study (08-10-24)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- Glioblastoma - Clinical Trial (08-06-234)
- Diabetes Study (08-046)
- Cystitis-Painful Bladder Study - (08-269)
- Pelvic Pain Study - (08-274)
- Schizophrenia - Clinical Trial (08-296)
- COPD - Clinical Trial (09-02-110)
- Meningioma Study (09-212)
- Systemic Lupus Erythematosus Study (09-122)
- Brain Tumor Study (09-308)
- Women with Epilepsy - Pregnancy Outcomes and Deliveries - WEPOD
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
-
Neurosciences
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment and at Six Month Follow-up (11-196A)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
- Brain and Behavior in Dystonia Study (08-283)
- Brain AVM - Clinical Trial (06.02.063)
- Brain Networks in Parkinson's Disease (04-113T)
- Cannabis - Dopamine Study - (09-002)
- Clinical Correlates of Memory Impairment (03.08.160)
- Dementia - Clinical Trial (08-295)
- Dystonia - Deep Brain Stimulation Study (06-109T)
- Epilepsy
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Epilepsy - Genetic Marker and Enzyme Study (07.08.009)
- Epilepsy - Multicenter Study (06.08.058)
- Glioblastoma - Clinical Trial (08-06-234)
- Huntington's Disease - Clinical Trial (09-012)
- Huntington's Disease - Coenzyme Q10 Study (07-124)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Memory Disorders Study (08-219)
- Metastatic Brain Tumor Study (08-10-24)
- MIF - Spinal Cord Injury Study (09-026)
- Movement Disorders - Functional Correlates Study (08-191)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Neuroendocrine Tumors - Imaging Study (03-117)
- Parkinson's Disease Genetics Database (07-057)
- Parkinson's Disease - Genetic Study (07-058)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Parkinson's Disease - Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel (B09-004)
- Parkinson’s Disease - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern Analysis
- Parkinson’s Disease - Efficacy, Safety, and Tolerability of Pioglitazone
- Parkinson’s Disease - Efficacy, Safety and Tolerability of CoganeTM (B10-046)
- Parkinson’s Disease - Efficacy and Safety of Sufinamide (B10-026)
- Parkinson’s Disease - Efficacy and Safety Study of Low and High Doses of Safinamide (10-02-48-031)
- Parkinson’s Disease - Metabolic Networks and the Cognitive Treatment Response in Parkinson’s Disease
- Parkinson’s Disease - Microvascular Changes in Parkinson’s Disease: Relationship to Levodopa-Induced Dyskinesia
- Parkinson’s Disease - Open-Label Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel (B10-039)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Schizophrenia-like Effects of Cannibinoids (09-157)
- Swallowing Therapy Study (07-130)
- Web-delivery Treatment for Substance Abuse (10-016A)
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health